Skip to main content

Table 1 Baseline characteristics of the subjects

From: Systemic immune-inflammatory index predicts fragility fracture risk in postmenopausal anemic females with type 2 diabetes mellitus: evidence from a longitudinal cohort study

Characteristics

All Participants

(n = 423)

Low-level SII

(≤ 381.32)

(n = 141)

Moderate-level SII

(381.32–629.46) (n = 141)

High-level SII

(≥ 629.46)

(n = 141)

P values

Age, years

69.00 (64.00,75.00)

67.00 (62.00,74.00)

70.00 (64.00,76.00)

72.00 (65.00,76.00)

0.012*

Osteoporosis, n (%)

    

0.740

 No

129 (30.5)

46 (32.6)

43 (30.5)

40 (28.4)

 

 Yes

294 (69.5)

95 (67.4)

98 (69.5)

101 (71.6)

 

Hypertension, n (%)

    

 < 0.001*

 No

146 (34.5)

68 (48.2)

45 (31.9)

33 (23.4)

 

 Yes

277 (65.5)

73 (51.8)

96 (68.1)

108 (76.6)

 

DPN, n (%)

    

0.777

 No

158 (37.4)

56 (39.7)

51 (36.2)

51 (36.2)

 

 Yes

265 (62.6)

85 (60.3)

90 (63.8)

90 (63.8)

 

PVD, n (%)

    

0.973

 No

41 (9.7)

13 (9.2)

14 (9.9)

14 (9.9)

 

 Yes

382 (90.3)

128 (90.8)

127 (90.1)

127 (90.1)

 

Fracture history, n (%)

    

0.965

 No

503 (77.9)

104 (73.8)

10 2(72.3)

103 (73.0)

 

 Yes

143 (22.1)

37 (26.2)

39 (27.7)

38 (27.0)

 

Duration of diabetes, years

10.00 (3.00,16.00)

8.00 (2.00,16.00)

10.00 (3.00,16.50)

9.00 (3.00,15.00)

0.284

BMI, kg/m2

24.24 (22.07,26.78)

24.22 (22.35,26.91)

24.61 (22.50,26.81)

23.83 (21.48,26.51)

0.252

FBG, mmol/L

7.27 (5.64,9.62)

6.80 (5.44,9.19)

7.59 (5.76,9.73)

7.28 (5.66,10.38)

0.315

HbA1c, %

8.20 (6.90,10.40)

8.00 (6.60,10.60)

8.40 (7.05,10.50)

8.50 (6.80,10.25)

0.541

Hb, g/L

125.00 (115.00,134.00)

126.00 (117.00,134.00)

126.00 (118.50,135.00)

122.00 (105.50,133.00)

 < 0.001*

TSH, μIU/mL

1.68 (1.08,2.61)

1.72 (1.14,2.60)

1.68 (1.16,2.61)

1.62 (1.03,2.68)

0.902

FT3, pmol/L

4.50 (4.09,4.92)

4.52 (4.12,4.95)

4.56 (4.10,5.01)

4.37 (4.04,4.77)

0.066

FT4, pmol/L

11.25 (9.83,13.20)

10.88 (9.98,12.70)

11.26 (9.70,13.07)

11.69 (9.65,13.83)

0.293

TC, mmol/L

4.89 (4.00,5.75)

4.90 (4.04,5.77)

4.84 (4.00,5.70)

4.90 (3.89,5.78)

0.973

TG, mmol/L

1.42 (1.04,2.05)

1.42 (1.06,1.99)

1.46 (1.07,2.09)

1.38 (0.98,2.10)

0.814

HDL-C, mmol/L

1.17 (1.01,1.38)

1.16 (0.99,1.35)

1.21 (1.03,1.42)

1.14 (0.99,1.36)

0.191

LDL-C, mmol/L

2.92 (2.27,3.61)

2.94 (2.30,3.62)

2.92 (2.27,3.59)

2.88 (2.28,3.58)

0.982

Cr, μmol/L

65.00 (55.00,80.00)

63.00 (53.50,72.50)

64.00 (55.00,78.50)

68.00 (54.50,94.50)

0.034*

UA, μmol/L

317.00 (267.00,390.00)

316.00 (266.50,394.50)

321.00 (263.00,376.00)

317.00 (272.00,392.00)

0.976

Ca, mmol/L

2.27 (2.20,2.36)

2.28 (2.20,2.36)

2.29 (2.23,2.37)

2.26 (2.17,2.35)

0.034*

25(OH) D, nmol/L

54.42 ± 22.54

58.75 ± 22.97

55.44 ± 23.16

49.06 ± 20.46

0.001*

ALB, g/L

38.40 (35.30,41.00)

38.90 (36.70,41.55)

39.00 (36.15,41.00)

36.40 (32.40,40.00)

 < 0.001*

SII

481.72 (337.92–721.26)

274.29 (226.13–337.90)

481.72 (424.43–526.97)

904.25 (722.28–1294.11)

 < 0.001*

LS BMD, g/cm2

0.744 (0.657,0.841)

0.733 (0.655,0.832)

0.770 (0.674,0.859)

0.732 (0.649,0.824)

0.138

FN BMD, g/cm2

0.556 (0.494,0.631)

0.586 (0.510,0.655)

0.555 (0.504,0.625)

0.539 (0.458,0.613)

0.011*

TH BMD, g/cm2

0.704 ± 0.130

0.722 ± 0.127

0.711 ± 0.129

0.679 ± 0.132

0.016*

FRAX MOF, %

6.10 (4.10,9.60)

5.60 (3.65,8.55)

6.20 (4.40,9.45)

7.20 (4.20,12.00)

0.025*

FRAX HF, %

2.30 (1.10,4.40)

1.90 (0.80,3.65)

2.40 (1.30,4.10)

2.80 (1.20,6.10)

0.009*

  1. Mean ± standard deviation (SD) and median (interquartile range, IQR) for continuous variables. Percentages (%) for categorical variables
  2. Abbreviations: DPN diabetic peripheral neuropathy, PVD peripheral vascular disease, BMI body mass index, FBG fasting blood glucose, HbA1c glycated hemoglobin, Hb hemoglobin, TSH thyroid stimulating hormone, FT3 free triiodothyronine, FT4 free thyroxine, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Cr creatinine, UA uric acid, Ca calcium, 25(OH) D 25-hydroxy vitamin D, ALB serum albumin, BMD bone mineral density, SII systemic immune-inflammatory index, LS lumbar spine, FN femoral neck, TH total hip, FRAX fracture risk assessment tool, MOF major fracture, HF hip fracture
  3. *P < 0.05